Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Robert F. Kennedy Jr. petitioned the FDA to revoke authorization of the shots when they were in high demand and thousands of ...

The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

The amended lawsuit, filed in July 2022, sought a court order requesting that the agency reconsider granting authorization for Pfizer and Moderna Covid vaccines for children. Image An 11-year-old ...

Pfizer Inc. and Moderna Inc. have been developing ... people who have received two shots of existing vaccines. Japan is currently providing booster shots for certain segments of the population ...

What happened to the need to end commuting and presenteeism? Or to our gratitude for healthcare workers or our resolution to ...

to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron subvariants BA.4 and BA.5. The US regulator has cleared a 30 µg booster dose of a new ...

The two companies have submitted data from a phase 1 trial in support of the booster dose to the ... of either the Pfizer/BioNTech or Moderna COVID-19 vaccines for people with "moderately to ...

Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and distribute ahead of ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...